Barclays »

Aspire Biopharma Hldgs Inc Wt Exp 021430 shares owned by Barclays

Quarter-by-quarter ownership of Aspire Biopharma Hldgs Inc Wt Exp 021430 (ASBPW) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aspire Biopharma Hldgs Inc Wt Exp 021430

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs Inc Wt Exp 021430 held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs Inc Wt Exp 021430 by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $11k 350k 0.03
2025-06-30 $16k 350k 0.05
2025-03-31 $31k 350k 0.09

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430

Adage Capital Partners GP
Saba Capital Management
Linden Advisors
Aristeia Capital
Highbridge Capital Management
Toronto-Dominion Bank
OZ Management
Verition Fund Management
Barclays
Clear Street
Millennium Management
Alberta Investment Management Corporation
Antara Capital
D. E. Shaw & Co
Wolverine Asset Management

View all funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430